Objective Long-term safety concerns have been raised that the use of paclitaxel-coated
balloons and stents is linked to excess mortality. Our objective was to compare outcomes in …

Objective The aim of this study was to determine the survival of patients after use of
paclitaxel coated devices (PCX), as a recent meta-analysis of randomised trials reported …

Purpose In view of a recent meta-analysis reporting increased mortality following
angioplasty with paclitaxel-coated devices in peripheral arteries, we performed a patient …

Background Strategies for the most effective treatment for peripheral arterial disease (PAD)
remain controversial among clinicians. Several trials have shown improved primary patency …

Background Clinical benefit of paclitaxel-coated devices for patients with peripheral arterial
disease has been confirmed in randomized controlled trials (RCTs). A meta-analysis …

Purpose: A late increased mortality risk has been reported in a summary level meta-analysis
of patients with femoropopliteal artery occlusive disease treated with paclitaxel-coated …

Background Peripheral vascular devices (stents and balloons) coated with paclitaxel were
developed to address suboptimal outcomes associated with percutaneous revascularization …

Background Several randomized controlled trials (RCT s) have already shown that
paclitaxel‐coated balloons and stents significantly reduce the rates of vessel restenosis and …

Objective The treatment of femoropopliteal peripheral artery disease (PAD) using paclitaxel-
coated devices (PCDs) has been shown to improve patency in several randomized trials …

Importance In a recent meta-analysis of randomized clinical trials, femoropopliteal artery
revascularization with paclitaxel drug-coated devices was associated with increased long …